Prediction of erectile function following treatment for prostate cancer. - Wikidata - wikimedia - TriplyDB

Prediction of erectile function following treatment for prostate cancer.

Prediction of erectile function following treatment for prostate cancer.

http://www.wikidata.org/entity/Q37318611

about

Surgery and hormonal treatment for prostate cancer and sexual function Treatment options for localized prostate cancer Are we ready to predict late effects? A systematic review of clinically useful prediction models.Current status of penile rehabilitation after radical prostatectomy Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity.Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.Intraoperative Optical Biopsy during Robotic Assisted Radical Prostatectomy Using Confocal Endomicroscopy.Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status.Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy.Development of UK recommendations on treatment for post-surgical erectile dysfunction.Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy.Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial A manifesto on the preservation of sexual function in women and girls with cancer.Overview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment Can erectile function be predicted after prostate cancer treatment?Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment.Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study.Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment.Quality of Life and Sexual Health in the Aging of PCa Survivors.Sexual dysfunction in 2011: advances in epidemiology, pathophysiology and treatment.Canadian prostate brachytherapy in 2012.Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects.Eroticization as a factor influencing erectile dysfunction treatment effectiveness.Potency preservation following stereotactic body radiation therapy for prostate cancer.Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.Development of clinical models for predicting erectile function after localized prostate cancer treatment.

P2860

Q26773774-D6865DEE-245F-4588-BF8E-57FB365A9C53 Q26825653-DD81A46D-61FB-4059-8E01-939E2BE9F272 Q27311616-76564D8F-E9A7-447E-B85F-D94B1040E6A3 Q27693838-39BA160A-8178-4E42-AF43-D46215E167EA Q30234092-28C33EE5-A6F9-4E37-99C9-F4E38A269862 Q30234760-33135823-DED3-4003-A5C0-3A5BC4971728 Q30762097-2E31C749-DD99-4DAD-B276-AC989A78B85C Q30845863-F0A7B448-383F-4DBD-A4EB-5E2BA655095E Q33893074-0A21631F-4289-4D9C-86AB-1F8565646E7C Q34315605-F77F6A6A-990E-4ADD-836E-585720162447 Q34500966-BE384F64-08CD-407A-ACC3-6CB618171FDA Q34641767-3EBB494A-6092-4A52-A660-C484E0C99154 Q34788432-0D19D2C2-3425-4DE4-A516-C78E1BE90139 Q36161863-A4F1D7E4-A95E-4F52-8033-BC4900EDBC5E Q36345217-DD0DFC3E-1CB5-412F-888B-5E9E1BF41940 Q36407045-1EDA4F22-D0B7-49C1-802F-96B6C13F46C1 Q36520539-1085DD19-F17A-412B-AC65-77F227609EAC Q36672778-0E4CFCF4-4AE6-4C0D-BB71-302A2B7AA303 Q36740528-8271A67B-3CAF-4B28-98F8-E93EE4B7F353 Q36868048-823E2918-352A-49A4-992E-A58E162E3A54 Q36925871-AD6B51AB-34D8-4125-AA3E-EE538A7E4949 Q37035993-C98BDE11-8632-4CB4-8E95-FD591EAE09D5 Q37059743-6E4A7E97-5B80-48FD-A0D6-185044A4EE3D Q37074583-F7AAA596-1503-4DEF-AE09-07FA9679E846 Q37222409-49438C16-1CA2-4E71-AC17-0EC9870D4383 Q37240940-BAD002E2-6315-49BD-ABBF-2F418A65C175 Q37253743-02FF899D-0A0A-4CEC-86D9-D68C9FB3D6EA Q37283218-C9A390C7-23EF-4479-8D31-4C648289A45F Q37523203-C41D2D30-DEC4-43BE-B79C-E9D5702271DC Q37585270-E42E5692-7F04-4FCC-A5AA-BD8DCCC9B77B Q37624254-E10DA2D1-D342-45EC-8FA7-5DF2FA5545BC Q37647245-1E8BBDD5-ABF7-449E-9055-44DD530AA59A Q37686901-205CD836-6A57-4260-B6B1-A1F7B6A41069 Q37974503-6C7EB26E-8F3D-4E9C-9C73-0A6EB5E398A0 Q38106699-2E6AC5B1-91D9-4545-8CC8-12854E331F40 Q38115726-DA1E022D-AF3E-472E-9C78-0D211BB74980 Q38119063-86AF7A88-8139-40C1-96A1-DF23EA0FAA4F Q38158080-3BC980D2-1B43-4CA0-8675-29A9F0CD3780 Q38198624-D7E2658B-7D00-4005-96B6-99FDDA97D3CE Q38233280-69F1BCB9-24C3-4E97-A165-726ABCF380B5

P2860

Prediction of erectile function following treatment for prostate cancer.

http://www.wikidata.org/entity/Q37318611

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prediction of erectile function following treatment for prostate cancer.

@en

Prediction of erectile function following treatment for prostate cancer.

@nl

type

label

Prediction of erectile function following treatment for prostate cancer.

@en

Prediction of erectile function following treatment for prostate cancer.

@nl

prefLabel

Prediction of erectile function following treatment for prostate cancer.

@en

Prediction of erectile function following treatment for prostate cancer.

@nl

P1433

Q37318611-D5231114-073A-4A4C-B8AA-35DC8C90A99D

P1476

Q37318611-CAA3845D-1C20-4348-9F13-A10AA8D04425

P2093

Q37318611-008ECC63-E2E4-465B-A2E7-BEB40C22760F

Q37318611-1D9F9343-8C9F-4C24-8C2B-1FA67C779B72

Q37318611-217878F8-107D-43BA-B47D-A276D1865221

Q37318611-34E3B90A-76A4-42BC-A588-1CC26AA71430

Q37318611-5838C083-0A85-4CC5-B159-51A923DDA901

Q37318611-64AD2329-21DF-4309-BF22-9F264941FDD3

Q37318611-6CF3C4D5-5CAB-4EC0-9409-C6F0AC1A8079

Q37318611-80A0E531-07DB-4074-A6D3-104090B753E0

Q37318611-9063DE9F-A105-48F0-A225-F26AF3291C3E

Q37318611-94F39908-4602-41A7-9DB7-61554C34AE6B

P2860

Q37318611-0A762F71-DBCD-4F4E-9918-80F0920DF321

Q37318611-1048F636-6211-40E0-986B-EAA79115E6B4

Q37318611-148E19DC-4CA9-4326-A158-AACB9B105C5B

Q37318611-19ED5E69-983A-411B-AE9B-2E639BBF235C

Q37318611-1A5415CF-2528-443A-B218-8455B345BB66

Q37318611-1DA3F199-3849-49F8-8DF9-FF0DA742C935

Q37318611-2F232856-726B-4647-8D51-851E29019302

Q37318611-334BF57C-58AD-49A4-9B13-FF33BE3E0936

Q37318611-454D3AC5-EE7C-40D9-A06D-C45FC12BC7BB

Q37318611-48F12344-353C-4014-B72E-BC5ED0A4FF95

P304

Q37318611-777B576D-6586-4908-A22F-FF02F9370CC0

P31

Q37318611-A53BBF15-0801-475B-A43F-ACF388EDEA9A

P356

Q37318611-F107732D-9CD2-41C7-ABF9-85B075199FA5

P407

Q37318611-E1BF931D-81A0-44D5-9E87-D47291057F10

P433

Q37318611-5639C55C-ACFA-47D0-B0A6-B090AE6F8A8B

P478

Q37318611-8455A326-68DB-47A5-989A-41B44863216D

P50

Q37318611-616715C1-1E8C-4584-995F-F2DF2C2E0DA6

P577

Q37318611-A643C6DF-215A-4FA4-99E2-D3BE76542BD6

P5875

Q37318611-4E895B1A-0720-4B65-9AED-D11825A37109

P698

Q37318611-2F18DC4D-75EF-4665-9090-5D66B45DC8A6

P932

Q37318611-8CF32733-69D2-41A0-8178-C7A07CA37083

P356

P1433

Journal of the American Medical Association

P1476

Prediction of erectile function following treatment for prostate cancer.

@en

P2093

Adam S Kibel

http://www.w3.org/2001/XMLSchema#string

Christopher S Saigal

http://www.w3.org/2001/XMLSchema#string

Daniel A Hamstra

http://www.w3.org/2001/XMLSchema#string

David P Wood

http://www.w3.org/2001/XMLSchema#string

Deborah A Kuban

http://www.w3.org/2001/XMLSchema#string

Eric Klein

http://www.w3.org/2001/XMLSchema#string

Howard M Sandler

http://www.w3.org/2001/XMLSchema#string

Irving D Kaplan

http://www.w3.org/2001/XMLSchema#string

Jay Ciezki

http://www.w3.org/2001/XMLSchema#string

Jeff M Michalski

http://www.w3.org/2001/XMLSchema#string

P2860

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

Prediction of sexual function after radical prostatectomy.

Determinants of sexual satisfaction in men with prostate cancer.

Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles.

Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.

P304

1205-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.1333

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

Matthew R Cooperberg

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51657922

http://www.w3.org/2001/XMLSchema#string

P698

21934053

http://www.w3.org/2001/XMLSchema#string

P932

3831607

http://www.w3.org/2001/XMLSchema#string